Tracheostomy in the COVID-19 pandemic.
Eur Arch Otorhinolaryngol
; 277(7): 2133-2135, 2020 Jul.
Article
in English
| MEDLINE | ID: covidwho-1049646
ABSTRACT
PURPOSE:
The role of tracheostomy in COVID-19-related ARDS is unknown. Nowadays, there is no clear indication regarding the timing of tracheostomy in these patients.METHODS:
We describe our synergic experience between ENT and ICU Departments at University Hospital of Modena underlining some controversial aspects that would be worth discussing tracheostomies in these patients. During the last 2 weeks, we performed 28 tracheostomies on patients with ARDS due to COVID-19 infection who were treated with IMV.RESULTS:
No differences between percutaneous and surgical tracheostomy in terms of timing and no case of team virus infection.CONCLUSION:
In our experience, tracheostomy should be performed only in selected patients within 7- and 14-day orotracheal intubation.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Respiratory Distress Syndrome
/
Tracheostomy
/
Coronavirus Infections
/
Minimally Invasive Surgical Procedures
/
Intubation, Intratracheal
Type of study:
Diagnostic study
/
Observational study
/
Prognostic study
Limits:
Adult
/
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Eur Arch Otorhinolaryngol
Journal subject:
Otolaryngology
Year:
2020
Document Type:
Article
Affiliation country:
S00405-020-05982-0
Similar
MEDLINE
...
LILACS
LIS